Health
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy
HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against durvalumab (PD-L1) combination the...
Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL
– establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable ingredients from natural sources, announced today the signing of a binding and definitive agreement to acquire the multipurpose production ...
Heartbeats: 230,000 Views for Dr. Kiat's Everyday Lunch - A Viral Lesson That Science Has No Borders
SYDNEY, Sept. 2, 2025 /PRNewswire/ -- A humble lunch video from world-renowned cardiologist Dr. Hosen Kiat has captured more than 230,000 views on Chinese social media Little Red Book. Shared as part of his new digital wellness initiative with Heartbeats, the "real-style" post featured nothing mo...
SteriLance Safety Lancets Adopted Across Thailand's Public-Hospital Channels
BANGKOK, Sept. 2, 2025 /PRNewswire/ -- SteriLance Medical announced that its safety lancet portfolio — PRESS PLUS, IMPRESS and LITE3 — has been adopted withinThailand's public-hospital channels following a tender awarded by a nationally recognized humanitarian organization. Supply and post-market...
LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company
Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships SEOUL, South Korea and SYRACUSE, N.Y., Sept. 2, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEOJames Park) today announced that it has entered a late-stage to commercial contract manufacturing par...
AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction
* AMI Pharm's 'AYP-101' Sets to Become a New Leader in Nonsurgical Fat Reduction with Phase 2 Trial Success * 'AYP-101,' a Promising Nonsurgical Solution, Has Its Clinical Results Published in Clinical Therapeutics * 'AYP-101' Demonstrates Superior Safety and Efficacy, Poised to Change the ...
Norma Completes Quantum AI Algorithm Validation on NVIDIA
"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" * Norma, a quantum computing company, has validated the performance of quantum AI algorithms using NVIDIA CUDA-Q. * By running these algorithms for drug development on CUDA-Q, Norma observed computational speeds up to 73 times faster. * The com...
Introducing FitTransformer: The World's First Modular Smart Gym That Transforms Your Home Workouts
PHOENIX, Sept. 1, 2025 /PRNewswire/ -- Today marks the official launch of
FitTransformer
Data4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation
POTSDAM, Germany, Sept. 1, 2025 /PRNewswire/ -- Data4Life announces that the Hasso Plattner Foundation, as the supporting foundation of the organization, has appointed Dr. Ben Illigens as its new Chief Executive Officer (CEO). He succeedsChristian Weiss, who has shaped the development phase of D...
Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches
ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human study in 2019 followed by sustaining long-term results and a successful Randomized Contr...
Rosti to Showcase Next-Generation Medical Manufacturing Solutions at MedTec China 2025
SHANGHAI, Sept. 1, 2025 /PRNewswire/ -- Shanghai, September 24–26, 2025 – Stand 1D402 Rosti Integrated Manufacturing Solutions (Suzhou) Co., Ltd., part of the Rosti Group, will highlight its expanding medical device capabilities at MedTec China 2025, showcasing advanced medical injection mouldin...
CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry
GUANGZHOU, China, Sept. 1, 2025 /PRNewswire/ -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is set to take place from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) inGuangzhou. Themed "Health, Innovation, Collaboration," ...
Jenscare, releases 2025H1 interim results
BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 endedJune 30, 2025...
AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work
SINGAPORE, Sept. 1, 2025 /PRNewswire/ -- Great Place To Work®, the global
authority on workplace culture, has selected AbbVie for the2025 Best Workplaces
in Asia™ List
Jenscare Announces 2025H1 Interim Results
BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases, achieved key milestones in its product portfolio and just announced its interi...
The Veteran Suite partners with QENDO to advocate for female veteran care
SYDNEY, Sept. 1, 2025 /PRNewswire/ -- The Veteran Suite, a medical centre exclusively for Australian veterans and their families, has launched a new partnership with QENDO, an Australian organisation providing support and education for those affected by endometriosis, adenomyosis, PCOS, infertili...
LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased
HONG KONG, Aug. 30, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral ...
Jacobio Pharma Announces 2025 Interim Results
BEIJING and SHANGHAI and BOSTON, Aug. 29, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced its interim results for the six months endedJune 30, 2025. During the reporting period, the Company achieved revenue of RMB45.7 million, representing a 100% increase compared with the same per...
Lifezoom Updates: Refining Efficient Light Therapy Products Based on Customer Insights
NEW YORK, Aug. 29, 2025 /PRNewswire/ -- Since its launch, Lifezoom
Guo Guangchang: Fosun Strives to Break Through in Advantageous Sectors and Reach the Global Pinnacle
HONG KONG, Aug. 29, 2025 /PRNewswire/ -- On the morning of 29 August, Guo Guangchang, Chairman of Fosun International, stated at the Company's 2025 interim results presentation that Fosun will continue to increase investment in biopharmaceuticals and focus on deepening and thoroughly developing i...
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07Synvo AI and Sobat Bisnis Group (SBG) Forge Strategic Partnership to Bring Secure, Context-Aware Enterprise AI to Indonesia and Southeast Asia
[Picked up by 290 media titles]
2025-12-16 08:00Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology
[Picked up by 287 media titles]
2025-12-16 14:26Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00